India's pharmaceutical industry is poised for significant growth, with its share in the global market expected to rise to 5 ...

The Indian pharma market, currently valued at around USD 55 billion, is projected to expand 2.2 to 2.4 times over the next ...

RA: What do you think the implications would be of restrictions to the FDI policy in pharma? TR: India witnessed the second highest growth ... industry, in the globalized economy. 2) Need for ...

Innovative healthcare delivery formats, spanning primary, secondary, remote health, and homecare, are transforming the way ...

where significant opportunities for growth and innovation exist. Despite the Indian pharmaceutical industry's notable achievements on the global stage, it lags behind its international ...

As India’s pharmaceutical and healthcare industries ... An increase in healthcare spending to 2.5-3% of GDP is necessary for sustained industry growth. With a strategic policy push, India is ...

Strong pricing growth (+5.3 per cent YoY) and the launch of new products from recent patent expiries (+2.6 per cent YoY ... selling English daily in North India, publishes news and views without ...

Indian pharmaceutical companies are increasingly investing in anticancer research and drug innovation as part of their strategy for future growth. With the global ... individual's unique needs. Our ...

As India Inc is eagerly ... It is expected that the pharmaceutical and healthcare industry will remain at the centre stage of the government’s growth agenda. Having grown from a market value ...

and would play a crucial role in shaping the next phase of growth for India's economy, according to top industry voices. Puneet Chandok, President, Microsoft India and South Asia said it is ...

According to Business Research Insights the Urokinase Market expected to exhibit a CAGR of 5.2% by 2033.The "Urokinase Market" Research is your essential resource for understanding the current ...